| Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications BN Singh, S Shankar, RK Srivastava Biochemical pharmacology 82 (12), 1807-1821, 2011 | 1659 | 2011 |
| Factors associated with death in critically ill patients with coronavirus disease 2019 in the US S Gupta, SS Hayek, W Wang, L Chan, KS Mathews, ML Melamed, ... JAMA internal medicine 180 (11), 1436-1447, 2020 | 964 | 2020 |
| Association between early treatment with tocilizumab and mortality among critically ill patients with COVID-19 S Gupta, W Wang, SS Hayek, L Chan, KS Mathews, ML Melamed, ... JAMA internal medicine 181 (1), 41-51, 2021 | 523 | 2021 |
| Proteogenomic characterization reveals therapeutic vulnerabilities in lung adenocarcinoma MA Gillette, S Satpathy, S Cao, SM Dhanasekaran, SV Vasaikar, K Krug, ... Cell 182 (1), 200-225. e35, 2020 | 479 | 2020 |
| Chemoprevention by resveratrol: molecular mechanisms and therapeutic potential S Shankar, G Singh, RK Srivastava Front Biosci 12 (12), 4839-4854, 2007 | 439 | 2007 |
| Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer SK Roy, RK Srivastava, S Shankar Journal of molecular signaling 5, 1-13, 2010 | 402 | 2010 |
| Resveratrol Inhibits Pancreatic Cancer Stem Cell Characteristics in Human and KrasG12D Transgenic Mice by Inhibiting Pluripotency Maintaining Factors and … S Shankar, D Nall, SN Tang, D Meeker, J Passarini, J Sharma, ... PloS one 6 (1), e16530, 2011 | 349 | 2011 |
| EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer. S Shankar, S Ganapathy, SR Hingorani, RK Srivastava Frontiers in bioscience: a journal and virtual library 13, 440-452, 2008 | 342 | 2008 |
| Targeting epigenetic regulation of miR-34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cells D Nalls, SN Tang, M Rodova, RK Srivastava, S Shankar PloS one 6 (8), e24099, 2011 | 320 | 2011 |
| Synergistic interactions of chemotherapeutic drugs and tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand on apoptosis and on regression of breast carcinoma … TR Singh, S Shankar, X Chen, M Asim, RK Srivastava Cancer research 63 (17), 5390-5400, 2003 | 320 | 2003 |
| Enhancement of therapeutic potential of TRAIL by cancer chemotherapy and irradiation: mechanisms and clinical implications S Shankar, RK Srivastava Drug resistance updates 7 (2), 139-156, 2004 | 300 | 2004 |
| Involvement of Bcl-2 family members, phosphatidylinositol 3'-kinase/AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer S Shankar, RK Srivastava International journal of oncology 30 (4), 905-918, 2007 | 291 | 2007 |
| Characteristics and outcomes of individuals with pre-existing kidney disease and COVID-19 admitted to intensive care units in the United States JE Flythe, MM Assimon, MJ Tugman, EH Chang, S Gupta, J Shah, ... American Journal of Kidney Diseases 77 (2), 190-203. e1, 2021 | 257 | 2021 |
| The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial … SN Tang, C Singh, D Nall, D Meeker, S Shankar, RK Srivastava Journal of Molecular Signaling 5, 1-15, 2010 | 254 | 2010 |
| Inhibition of sonic hedgehog pathway and pluripotency maintaining factors regulate human pancreatic cancer stem cell characteristics SN Tang, J Fu, D Nall, M Rodova, S Shankar, RK Srivastava International journal of cancer 131 (1), 30-40, 2012 | 243 | 2012 |
| Green tea polyphenols: biology and therapeutic implications in cancer S Shankar, S Ganapathy, RK Srivastava Front Biosci 12 (4881), 99, 2007 | 238 | 2007 |
| Rottlerin induces autophagy and apoptosis in prostate cancer stem cells via PI3K/Akt/mTOR signaling pathway D Kumar, S Shankar, RK Srivastava Cancer letters 343 (2), 179-189, 2014 | 234 | 2014 |
| Rottlerin induces autophagy which leads to apoptotic cell death through inhibition of PI3K/Akt/mTOR pathway in human pancreatic cancer stem cells BN Singh, D Kumar, S Shankar, RK Srivastava Biochemical pharmacology 84 (9), 1154-1163, 2012 | 232 | 2012 |
| Hedgehog signaling antagonist GDC-0449 (Vismodegib) inhibits pancreatic cancer stem cell characteristics: molecular mechanisms BN Singh, J Fu, RK Srivastava, S Shankar PloS one 6 (11), e27306, 2011 | 230 | 2011 |
| Resveratrol induces growth arrest and apoptosis through activation of FOXO transcription factors in prostate cancer cells Q Chen, S Ganapathy, KP Singh, S Shankar, RK Srivastava PloS one 5 (12), e15288, 2010 | 216 | 2010 |
Rakesh SrivastavaLouisiana State University Health Sciences Center在 lsuhsc.edu 的电子邮件经过验证
